Sanofi teams up with basketball star to promote OTC Nasacort; Novartis mistakenly touts Zykadia approval;

> Sanofi ($SNY) has brought on former WNBA star and coach Nancy Lieberman to help promote its OTC version of allergy med Nasacort, a move it says will help allergy sufferers "put the full 'cort press" on symptoms. Release

> Novartis ($NVS) accidentally sent out a mass email announcing the FDA approval of lung cancer drug Zykadia--a drug the agency has not actually approved yet. News

> Pfizer's ($PFE) consumer healthcare unit has teamed up with actor Josh Duhamel for its Advil Relief in Action campaign, which features a Mobile Relief Center tour making about 100 stops across the country. More

> Keryx Biopharmaceuticals ($KERX) has appointed three executives to strategic roles in preparation for the anticipated launch of Zerenex. Release

> CDM Group has named Josh Prince as president of its portfolio of healthcare agencies. News (reg. req.)

> Insurers, now unable to turn away diabetics under the Affordable Care Act, are checking in with patients to ensure adherence to their diet plans and medications. Report

> Sanofi ($SNY) has launched a £50,000 U.K. patient group fund, which supports organizations that promote patient interests. More

> Teva ($TEVA) has launched a generic of Sunovion's insomnia treatment Lunesta. Report

And Finally... Pfizer ($PFE) has reminded the creator of celebrity-commissioned Viagra-laced ice cream that its erectile dysfunction treatment should be prescribed by a healthcare professional and used according to its labeling. More

Suggested Articles

Novartis hopes to leverage its existing presence in the hematology community to achieve a successful launch of Adakveo.

Compared with the FDA "boxed warning," the EMA version puts a smaller restriction on the higher dose but broadens the cautionary language.

To show Brukinsa is better than AbbVie and J&J's blockbuster Imbruvica, BeiGene is running phase 3 head-to-head trials in blood cancers.